Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoids”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01396382
What this trial is testing

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Carcinoma
Vanderbilt-Ingram Cancer Center 97
Early research (Phase 1)Study completedNCT00339131
What this trial is testing

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Who this might be right for
PheochromocytomaParagangliomaCarcinoid
Molecular Insight Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT01018953
What this trial is testing

Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 8
Testing effectiveness (Phase 2)Study completedNCT02575300
What this trial is testing

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Carcinoid TumorsPancreatic NET
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Testing effectiveness (Phase 2)UnknownNCT02038738
What this trial is testing

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Who this might be right for
NeuroendocrineNeuroendocrine TumorNeuroendocrine Cancer+5 more
Ochsner Health System 250
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)UnknownNCT02455596
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 20
Early research (Phase 1)Study completedNCT00020124
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Large-scale testing (Phase 3)Study completedNCT02063659
What this trial is testing

Telotristat Etiprate for Carcinoid Syndrome Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 76
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00020007
What this trial is testing

Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Large-scale testing (Phase 3)Looking for participantsNCT07087054
What this trial is testing

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 141
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Early research (Phase 1)Study completedNCT00942682
What this trial is testing

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT00055809
What this trial is testing

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Who this might be right for
Metastatic Gastrointestinal Carcinoid TumorRecurrent Gastrointestinal Carcinoid TumorRegional Gastrointestinal Carcinoid Tumor
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)WithdrawnNCT00696930
What this trial is testing

Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors

Who this might be right for
Malignant Carcinoid Tumor
Molecular Insight Pharmaceuticals, Inc.
Not applicableNo Longer AvailableNCT02375464
What this trial is testing

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Northwell Health
Next Page